Sales Reflect Continued Strong Growth in Oncology and Vaccines
Total Worldwide Sales Were $15.8 Billion, an Increase of 9% From First Quarter 2023; Excluding the Impact of Foreign Exchange,.
Measles is not a harmless childhood disease. It's dangerous and can be life-threatening. Our most effective public health measure against measles is prevention with a measles vaccine. Vaccines approved by the FDA for the prevention of measles are proven both safe and effective.
Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines
Fourth-Quarter Worldwide Sales Were $14.6 Billion, an Increase of 6% From Fourth Quarter 2022; Excluding.
Controversy over residual DNA in COVID-19 vaccines. Experts refute claims that it could cause cancer or alter DNA. Regulatory agencies confirm safe levels of DNA.
Sales Reflect Sustained Growth, Particularly in Oncology and Vaccines
Total Worldwide Sales Were $16.0 Billion, an Increase of 7% From Third Quarter 2022; Excluding LAGEVRIO, Growth Was 6%;.